Raymond James & Associates Decreases Stock Position in Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Raymond James & Associates lessened its stake in Crescent Capital BDC, Inc. (NASDAQ:CCAP) by 4.2% in the fourth quarter, Holdings Channel reports. The fund owned 140,104 shares of the company’s stock after selling 6,199 shares during the quarter. Raymond James & Associates’ holdings in Crescent Capital BDC were worth $2,435,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Jump Financial LLC boosted its holdings in Crescent Capital BDC by 4.6% in the 3rd quarter. Jump Financial LLC now owns 19,559 shares of the company’s stock worth $334,000 after acquiring an additional 859 shares during the period. Cobblestone Capital Advisors LLC NY boosted its holdings in Crescent Capital BDC by 1.6% in the 3rd quarter. Cobblestone Capital Advisors LLC NY now owns 59,557 shares of the company’s stock worth $1,018,000 after acquiring an additional 965 shares during the period. LPL Financial LLC boosted its holdings in Crescent Capital BDC by 2.8% in the 3rd quarter. LPL Financial LLC now owns 40,310 shares of the company’s stock worth $689,000 after acquiring an additional 1,084 shares during the period. UBS Group AG boosted its holdings in Crescent Capital BDC by 48.2% in the 1st quarter. UBS Group AG now owns 6,645 shares of the company’s stock worth $118,000 after acquiring an additional 2,160 shares during the period. Finally, Captrust Financial Advisors boosted its holdings in Crescent Capital BDC by 3.7% in the 4th quarter. Captrust Financial Advisors now owns 63,194 shares of the company’s stock worth $808,000 after acquiring an additional 2,250 shares during the period. Hedge funds and other institutional investors own 49.46% of the company’s stock.

Crescent Capital BDC Stock Performance

Shares of CCAP opened at $16.96 on Tuesday. The business’s 50 day moving average is $16.89 and its two-hundred day moving average is $16.76. Crescent Capital BDC, Inc. has a 52-week low of $13.11 and a 52-week high of $18.00. The firm has a market cap of $628.54 million, a price-to-earnings ratio of 7.41 and a beta of 0.83. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 1.14.

Crescent Capital BDC (NASDAQ:CCAP) last announced its earnings results on Wednesday, February 21st. The company reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.57 by $0.04. Crescent Capital BDC had a return on equity of 11.32% and a net margin of 45.54%. The company had revenue of $50.00 million for the quarter, compared to analyst estimates of $47.99 million. Analysts forecast that Crescent Capital BDC, Inc. will post 2.26 EPS for the current fiscal year.

Crescent Capital BDC Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Friday, March 29th were given a dividend of $0.41 per share. This represents a $1.64 annualized dividend and a dividend yield of 9.67%. The ex-dividend date of this dividend was Wednesday, March 27th. Crescent Capital BDC’s dividend payout ratio is currently 71.62%.

Wall Street Analyst Weigh In

A number of research firms have weighed in on CCAP. Wells Fargo & Company upped their price target on Crescent Capital BDC from $16.00 to $16.50 and gave the stock an “equal weight” rating in a report on Monday, January 29th. Oppenheimer upped their target price on Crescent Capital BDC from $18.00 to $19.00 and gave the company an “outperform” rating in a research report on Friday, February 23rd.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.